RSCM
Rock Springs Capital Management’s Evolent Health EVH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Buy |
2,820,700
+125,000
| +5% | +$1.41M | 1.98% | 18 |
|
|
2025
Q1 | $25.5M | Buy |
2,695,700
+635,700
| +31% | +$6.02M | 1.46% | 27 |
|
|
2024
Q4 | $23.2M | Sell |
2,060,000
-10,000
| -0.5% | -$113K | 0.88% | 40 |
|
|
2024
Q3 | $58.5M | Sell |
2,070,000
-2,007,500
| -49% | -$56.8M | 1.9% | 14 |
|
|
2024
Q2 | $78M | Buy |
4,077,500
+90,000
| +2% | +$1.72M | 2.35% | 9 |
|
|
2024
Q1 | $131M | Buy |
3,987,500
+27,500
| +0.7% | +$902K | 3.32% | 4 |
|
|
2023
Q4 | $131M | Buy |
3,960,000
+95,000
| +2% | +$3.14M | 3.22% | 7 |
|
|
2023
Q3 | $105M | Buy |
3,865,000
+61,500
| +2% | +$1.67M | 2.82% | 9 |
|
|
2023
Q2 | $115M | Hold |
3,803,500
| – | – | 2.74% | 9 |
|
|
2023
Q1 | $123M | Hold |
3,803,500
| – | – | 2.94% | 7 |
|
|
2022
Q4 | $107M | Buy |
3,803,500
+541,000
| +17% | +$15.2M | 2.57% | 10 |
|
|
2022
Q3 | $117M | Buy |
3,262,500
+524,500
| +19% | +$18.8M | 3.03% | 8 |
|
|
2022
Q2 | $84.1M | Buy |
2,738,000
+358,000
| +15% | +$11M | 2.45% | 8 |
|
|
2022
Q1 | $76.9M | Buy |
2,380,000
+342,000
| +17% | +$11M | 1.94% | 13 |
|
|
2021
Q4 | $56.4M | Buy |
2,038,000
+163,000
| +9% | +$4.51M | 1.3% | 23 |
|
|
2021
Q3 | $58.1M | Buy |
1,875,000
+175,957
| +10% | +$5.45M | 1.22% | 27 |
|
|
2021
Q2 | $35.9M | Buy |
1,699,043
+254,043
| +18% | +$5.37M | 0.71% | 50 |
|
|
2021
Q1 | $29.2M | Buy |
+1,445,000
| New | +$29.2M | 0.64% | 54 |
|